Polyp Burden Drops With Sulindac/Erlotinib Combo in FAP

Patients with familial adenomatous polyposis have an increased risk for colorectal polyps and cancer; however, treatment with a combination of sulindac and erlotinib reduced their colorectal polyp burden by more than two thirds.

Source: CancerNetwork - February 15, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Genetic Disorders News Source Type: news